Janus Henderson Group PLC Cyteir Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.62 - $4.4 $2.79 Million - $7.57 Million	-1,719,610 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.39 - $10.51 $518,029 - $1.61 Million	-152,811 Reduced 8.16%	1,719,610 $6.49 Million
Q4 2021 Feb 14, 2022	SELL	$9.83 - $19.21 $57,043 - $111,475	-5,803 Reduced 0.31%	1,872,421 $20.6 Million
Q3 2021 Nov 16, 2021	SELL	$14.57 - $21.86 $169,143 - $253,772	-11,609 Reduced 0.61%	1,878,224 $31.9 Million
Q2 2021 Aug 16, 2021	BUY	$16.8 - $21.4 $31.7 Million - $40.4 Million	1,889,833 New	1,889,833 $37.9 Million

2.47M

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.